Primolut‑N (Norethisterone) with Depo‑Provera: No Contraceptive Interference

Primolut‑N (norethisterone 5 mg) is a progestin used for menstrual regulation, endometriosis, or dysfunctional uterine bleeding. Depo‑Provera (DMPA) is a long‑acting injectable progestin contraceptive.

Interaction Assessment

  • Both are progestins; no pharmacokinetic interaction that reduces DMPA’s contraceptive efficacy.
  • DMPA suppresses ovulation primarily; norethisterone adds progestogenic effect (endometrial stabilization).
  • No evidence of increased pregnancy risk with concurrent use.

Clinical Context

  • Norethisterone often prescribed for breakthrough bleeding on DMPA (5 mg TID × 5–10 days).
  • Does not “cancel out” DMPA; next DMPA injection remains on schedule (every 11–13 weeks).

Caveats

  • Always inform all providers of all medications.
  • If norethisterone used for other indications (e.g., endometriosis), ensure DMPA timing maintained.
  • Individual metabolism varies; consult prescriber for personalized advice.

Pregnancy & Health - Related Articles